Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994622 | 12699462 | 2 | F | 20160826 | 20160830 | 20160909 | EXP | DE-HERITAGE PHARMACEUTICALS-2016HTG00211 | HERITAGE | KRUGER T, JOCKERS-SCHERUBL M, GROHMANN R, RUTHER E, DEGNER D. DEVELOPMENT OF EPILEPTIC SEIZURES UNDER THERAPY WITH OLANZAPINE AND VENLAFAXINE ER WITH FATAL OUTCOME. PSYCHOPHARMAKOTHERAPIE. 2016;23(3):125-128 | 76.00 | YR | F | Y | 0.00000 | 20160909 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994622 | 12699462 | 1 | PS | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | ^UP TO 112.5 MG^ | U | 78554 | |||||||||
| 126994622 | 12699462 | 2 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 MG, 1X/DAY | U | 0 | 5 | MG | QD | ||||||
| 126994622 | 12699462 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 2.5 MG, 1X/DAY | U | 0 | 2.5 | MG | QD | ||||||
| 126994622 | 12699462 | 4 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 2 X 110 MG/DAY | 0 | ||||||||||
| 126994622 | 12699462 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 5 MG, 1X/DAY | 0 | 5 | MG | QD | |||||||
| 126994622 | 12699462 | 6 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | UP TO 2 MG DAILY | U | 0 | |||||||||
| 126994622 | 12699462 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, 1X/DAY | 0 | ||||||||||
| 126994622 | 12699462 | 8 | C | OXYCODONE/NALOXONE | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Unknown | 2 X 10/5 MG/DAY | 0 | ||||||||||
| 126994622 | 12699462 | 9 | C | FESOTERODINE | FESOTERODINE | 1 | Unknown | 8 MG, 1X/DAY | 0 | 8 | MG | QD | |||||||
| 126994622 | 12699462 | 10 | C | CALCIUM | CALCIUM | 1 | Unknown | 500 MG, 1X/DAY | 0 | 500 | MG | QD | |||||||
| 126994622 | 12699462 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 15 MG, 1X/WEEK | 0 | 15 | MG | /wk | |||||||
| 126994622 | 12699462 | 12 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 1 DOSAGE UNITS, 1X/WEEK | 0 | 1 | DF | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126994622 | 12699462 | 1 | Depression |
| 126994622 | 12699462 | 2 | Depression |
| 126994622 | 12699462 | 4 | Deep vein thrombosis |
| 126994622 | 12699462 | 5 | Rheumatoid arthritis |
| 126994622 | 12699462 | 6 | Anxiety |
| 126994622 | 12699462 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126994622 | 12699462 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126994622 | 12699462 | Circulatory collapse | |
| 126994622 | 12699462 | Epilepsy | |
| 126994622 | 12699462 | Haemorrhage | |
| 126994622 | 12699462 | Multiple fractures |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |